The independent source for health policy research, polling, and news.
321 - 340 of 112,415 Results
Multiple scientists were dismissed Friday, effectively immediately. The board typically consists of 25 members from various scientific fields, appointed by the president for a six-year term. Critics say the scientists' dismissal, along with funding cuts, could have national consequences.
A Trump administration official said the man who rushed a security checkpoint "set out to target folks in the administration” and claimed to be a “friendly federal assassin.” Those who know the man described him as "a very nice guy,” "polite," and "peaceful." Plus, security concerns arise.
Today's early morning highlights from the major news organizations.
Editorial writers discuss these public health topics.
Each week, KFF Health News finds longer stories for you to enjoy. Today's selections are on children's health, solar power, microplastics, peptides, and more.
The measure, which is backed by Democratic Gov. Ned Lamont, would also require insurance coverage and allow Connecticut to purchase vaccines from sources other than the CDC.
The findings, published in the Journal of the American College of Cardiology, said that many deaths in the researchers' study could be explained by a range of causes, including hypertensive heart disease, dilated cardiomyopathy, substance-related cardiomyopathy, and normal heart primary electrical disease. "As a consequence, efforts should also be made to study the diagnosis and management of heart conditions other than ischemic cardiac disease," an accompanying editorial said.
Active-duty and retired service members have been contending with delayed and unpaid claims since the rollout of new Tricare contracts more than a year ago.
According to BioSpace, Moderna withdrew its approval application in the United States last May for the vaccine, which will carry the brand name mCOMBRIAX. The timeline for resubmission with the FDA remains uncertain.
A Senate-approved budget resolution to fund Homeland Security agencies does not include language to block funds from family planning clinics. Some lawmakers want the defunding provision included in the final bill. Congress must act before July.
To be eligible, certain breakthrough devices would have to be part of an Investigational Device Exemption study enrolling Medicare beneficiaries and assessing clinical outcomes agreed upon by the FDA and CMS, Modern Healthcare reported. Plus, President Donald Trump strikes a most-favored-nation deal with the final pharmaceutical holdout.
Today's early morning highlights from the major news organizations.
Opinion writers examine these public health topics.
Each week, KFF Health News compiles a selection of health policy studies and briefs.
Two anonymous women — a Jewish woman and a spiritual woman — and Hoosier Jews for Choice contend the state's abortion ban violates the Religious Freedom Restoration Act, the Post-Tribune reported. The Indiana Supreme Court has set oral arguments for Sept. 10.
Although roughly 140,000 people filed claims against Purdue Pharma, ProPublica and The Philadelphia Inquirer report that fewer than half of them will get any compensation under the new settlement. Meanwhile, other news is on rules for transgender students in New York, a deadly chemical leak at a West Virginia plant, chronic wasting disease in Delaware, and more.
The New York Times reports that since the hotline's rollout in 2022, the suicide rate among young people in the United States dropped 11% below projections. States with the largest volume of 988 calls saw an 18.2% reduction in suicides, while states with the lowest uptake saw a 10.6% reduction.
Three people familiar with the decision told The Washington Post that the report had cleared the scientific-review process but agency leadership had concerns about the methodology used to reach conclusions. That methodology has been used to determine the effectiveness of other vaccines, and those studies have been published, The Post wrote.
HHS Secretary Robert F. Kennedy Jr. told lawmakers on Capitol Hill on Wednesday, “We have advised every child to get the MMR [vaccine]. That’s what we do.” It is a statement he personally has not made. Plus, The New York Times explains the tightrope Kennedy is walking.
Licensed medical marijuana will now be listed as a Schedule III drug, which doesn't carry the same tight restrictions as a Schedule I drug. The order does not legalize cannabis, but it does allow researchers to conduct studies without facing penalties for possessing the substance.
© 2026 KFF